Judgment — ECLI:EU:T:2018:821
Date: 2018-11-22
Language of the case: English
Court formation: Fifth Chamber
Subject matter: Trade marks;Intellectual, industrial and commercial property
Procedure: Action for annulment - unfounded

Action brought on 5 February 2018 – Endoceutics v EUIPO – Merck (FEMIVIA) (Case T-59/18) Language in which the application was lodged: English Parties Applicant: Endoceutics, Inc. (Quebec, Quebec, Canada) (represented by: M. Wahlin, lawyer) Defendant: European Union Intellectual Property Office (EUIPO) Other party to the proceedings before the Board of Appeal: Merck KGaA (Darmstadt, Germany) Details of the proceedings before EUIPO Applicant of the trade mark at issue: Applicant Trade mark at issue: EU word mark ‘FEMIVIA’ – Application for registration No 13 148 986 Procedure before EUIPO: Opposition proceedings Contested decision: Decision of the Second Board of Appeal of EUIPO of 27 November 2017 in Case R 280/2017-2 Form of order sought The applicant claims that the Court should: annul the contested decision; order EUIPO to pay the Applicant’s costs both at EUIPO and at the General Court. Plea in law Infringement of Article 8(1)(b) of Regulation No 2017/1001. ____________